CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company
Corvus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CRVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464670809
- Phone
- (650) 900-4520
- Business address
- 901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $50,475
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$50,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-05-12 | Novo A/S 10% owner | Purchase | +70,000 | $10.00 | $700K | 3,224,046 |
| 2016-05-12 | MILLER RICHARD A MD President and CEO | Purchase | +30,000 | $10.00 | $300K | 1,076,993 |
| 2016-03-29 | Novo A/S 10% owner | Conversion | +2,130,492 | 2,130,492 | ||
| 2016-03-29 | Novo A/S 10% owner | Conversion | +356,888 | 2,487,380 | ||
| 2016-03-29 | Novo A/S 10% owner | Purchase | +666,666 | $15.00 | $10.0M | 3,154,046 |
| 2016-03-29 | Novo A/S 10% owner | Conversion · Series A Preferred Stock | −2,130,492 | 0 | ||
| 2016-03-29 | Novo A/S 10% owner | Conversion · Series B Preferred Stock | −356,888 | 0 | ||
| 2016-03-29 | ORBIMED ADVISORS LLC Director | Conversion | +3,994,674 | 3,994,674 | ||
| 2016-03-29 | ORBIMED ADVISORS LLC Director | Conversion | +713,776 | 4,708,450 | ||
| 2016-03-29 | ORBIMED ADVISORS LLC Director | Purchase | +550,000 | $15.00 | $8.3M | 5,258,450 |
| 2016-03-29 | ORBIMED ADVISORS LLC Director | Conversion · Series A Convertible Preferred Stock | −3,994,674 | 0 | ||
| 2016-03-29 | ORBIMED ADVISORS LLC Director | Conversion · Series B Convertible Preferred Stock | −713,776 | 0 | ||
| 2016-03-29 | Thompson Peter A. Director | Conversion | +3,994,674 | 3,994,674 | ||
| 2016-03-29 | Thompson Peter A. Director | Conversion | +713,776 | 4,708,450 | ||
| 2016-03-29 | Thompson Peter A. Director | Purchase | +550,000 | $15.00 | $8.3M | 5,258,450 |
| 2016-03-29 | Thompson Peter A. Director | Conversion · Series A Convertible Preferred Stock | −3,994,674 | 0 | ||
| 2016-03-29 | Thompson Peter A. Director | Conversion · Series B Convertible Preferred Stock | −713,776 | 0 | ||
| 2016-03-29 | ADAMS STREET PARTNERS LLC 10% owner | Conversion | +550,864 | 550,864 | ||
| 2016-03-29 | ADAMS STREET PARTNERS LLC 10% owner | Conversion | +92,278 | 643,142 | ||
| 2016-03-29 | ADAMS STREET PARTNERS LLC 10% owner | Purchase | +51,712 | $15.00 | $776K | 694,854 |
Page 16 of 19 · 371 trades